van der Geest, D., van Vliet, A., Peeper, D. S., Haanen, J. B. A. G., Smit, E. F., Theelen, W. S. M. E.

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

28 de November de 2025 by van der Geest, D., van Vliet, A., Peeper, D. S., Haanen, J. B. A. G., Smit, E. F., Theelen, W. S. M. E.

The introduction of immune checkpoint inhibitors (ICI) has revolutionized the treatment of many solid tumors including advanced non-small cell lung cancer (NSCLC) without targetable driver alterations. Unfortunately, the majority of patients with NSCL…